Vaping cessation is becoming increasingly critical as youth vaping rates soar, particularly among teens and young adults.Recent research shows that a new FDA-approved smoking cessation pill, varenicline, can significantly enhance the chance of quitting vaping, with participants achieving three times more success compared to others on placebo.